Oral Arsenic and Retinoic Acid for Non–High-Risk Acute Promyelocytic Leukemia

A pilot study reveals that an oral preparation of arsenic appears to be as effective as intravenous arsenic trioxide in inducing remissions in acute promyelocytic leukemia. The curative regimen may be administered on an outpatient basis in some cases.